KRT18 and metabolic dysfunction-associated steatohepatitis: CK18 is a biomarker of hepatocyte apoptosis that predicts and correlates to the development of hepatic inflammation, fibrosis, as well as non-alcoholic steatohepatitis (Maher et al., 2015).